Skip to main content
Contact Us
Careers
Quest
Research Portal
About Us
Back
Overview
Leadership Team
Our People, Our Values
Global Locations
Expertise
Back
All Expertise
Investment Banking
Back
Overview
M&A and Financial Advisory
Equity Capital Markets
Financial Sponsors
Debt Advisory & Restructuring
Corporate Broking and Investor Relations (UK)
Global Investment Banking Team
Research & Strategy
Sales & Trading
Corporate Access
Small Cap Navigator
Quest®
Sectors
Back
Overview
Blockchain & Digital Assets
Business Services
Consumer & Retail
Energy
Financials
Healthcare
Industrials / Aerospace & Defense
Metals & Mining
Real Estate & REITS
Sustainability
Technology
Transactions
News & Insights
Back
News
Insights
Events and Conferences
Search
Close
Search site
Search
March 2022
Aytu BioPharma, Inc.
US$8m
March 2022
Aytu BioPharma, Inc.
Sole Bookrunner (Follow-on Offering)
Healthcare
Equity Capital Markets
Canaccord Genuity Acted as Sole Bookrunner to Aytu BioPharma, Inc. on its $7.6 Million Follow-On Offering
More Like This
US$173m
June 2025
Omada Health
Co-Manager (IPO)
US$437m
May 2025
Hinge Health
Co-Manager (IPO)
US$484m
May 2025
Waystar
Co-Manager (Follow-On Offering)
View all Healthcare transactions
Close
